HomeNewsBusinessCompaniesUSFDA nod will open up lucrative market for us: Nectar Lifesciences

USFDA nod will open up lucrative market for us: Nectar Lifesciences

In an interview with CNBC-TV18, Dinesh Dua, CEO of Nectar Lifesciences said, "It’s going to happen at April. As soon as the approval is through we will be able to supply our API to lots of customers."

March 23, 2011 / 17:01 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

Integrated pharmaceutical company, Nectar Lifesciences  is awaiting the United States Food and Drug Administration (USFDA) inspection for it's active pharmaceutical ingredient (API) bulk pharma plant.

In an interview with CNBC-TV18, Dinesh Dua, CEO of Nectar Lifesciences said, "It
first published: Mar 23, 2011 04:19 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!